SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
66.50    6.50 (10.83%)
Bid:
66.00
Ask:
67.00
Spread: 1.00 (1.515%)
Market Cap: £52.41m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Holding(s) in Company

5 Oct 2016 18:10

RNS Number : 8211L
Hardide PLC
05 October 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Hardide plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Movement in issued share capital

X

3. Full name of person(s) subject to thenotification obligation: iii

Amati VCT 2 plc

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

5th October 2016

6. Date on which issuer notified:

5th October 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

4%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00B069T034

0

0

62,500,000

62,500,000

4.07%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

62,500,000

4.07%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Based on 1,534,906,304 shares in issue

14. Contact name:

Andrew Lynn

15. Contact telephone number:

0131 503 9105

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLAKPDKOBDDOKK
Date   Source Headline
1st Jun 20263:35 pmRNSHolding(s) in Company
27th May 20267:00 amRNSSignificant further order intake North America
21st May 20267:00 amRNSInterim Statement
5th May 20266:00 pmRNSHolding(s) in Company
28th Apr 20267:00 amRNSNew Order Intake and Notice of Interim Results
24th Mar 20264:30 pmRNSResult of AGM
24th Mar 20264:22 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAGM Trading Statement
20th Mar 20265:05 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSNotice of AGM
17th Mar 20267:00 amRNSNotice of AGM
11th Mar 202610:09 amRNSHolding(s) in Company
11th Mar 202610:09 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSFurther significant North American order intake
13th Feb 202612:03 pmRNSHolding(s) in Company
11th Feb 202611:35 amRNSDirector Dealings
10th Feb 202612:48 pmRNSGrant of Executive Share Options
3rd Feb 20267:00 amRNSSignificant New Order in North America
29th Jan 202611:17 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSAnnual results to 30 September 2025
12th Jan 20267:00 amRNSNotice of Results
1st Dec 20253:03 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSSignificant Orders from a Major New Customer
7th Nov 20258:53 amRNSHolding(s) in Company
24th Oct 20255:20 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSYear End Trading Update
28th May 20253:00 pmRNSDirector Dealings
27th May 20252:48 pmRNSDirector Dealings
20th May 20257:00 amRNSInterim Statement
18th Mar 20253:30 pmRNSResult of AGM
18th Mar 20257:00 amRNSAGM Trading Statement
4th Feb 20257:00 amRNSDirector Dealings
29th Jan 20257:00 amRNSAnnual results for year ended 30 September 2024
15th Jan 202510:00 amRNSNotice of Results
27th Dec 20247:00 amRNSGrant of Options and Issue of Shares
18th Dec 20247:00 amRNSNew Aerospace Supply Agreement
3rd Dec 20247:00 amRNSBoard Changes
21st Oct 20247:00 amRNSYear End Trading Update
18th Jun 20247:00 amRNSBoard Change and Appointment of Sole Broker
22nd May 20247:01 amRNSInterim Statement
22nd May 20247:00 amRNSAnnouncement of new Chief Executive Officer
8th May 20247:00 amRNSNotice of Results
1st May 202410:27 amRNSHolding(s) in Company
18th Apr 20245:40 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSLaunch of Ready Coated Component Range
25th Mar 20241:06 pmRNSResult of AGM
25th Mar 20247:00 amRNSAGM Statement
12th Mar 20242:57 pmRNSHolding(s) in Company
6th Mar 20245:10 pmRNSHolding(s) in Company
5th Mar 20243:02 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.